Alpha Cognition Inc. Receivables Turnover Ratio (ACOG), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Alpha Cognition Inc.  (Nasdaq: ACOG)
 

Alpha Cognition Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Alpha Cognition Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 3.63, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Alpha Cognition in Jun 30 2026 quarter, has decreased to 101 days, compared to 111 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector Alpha Cognition Inc. achieved the highest receivable turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2962, from overall ranking in the first quarter 2026 at 3131.

What is Receivable Turnover Ratio?
What is Alpha Cognition Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ACOG Receivables Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Receivable Change 189.09 % 516.61 % 4338.6 % 11895.56 % 3879.63 %
Y / Y Revenue Change 267.56 % 20.66 % - - -
Receivable Turnover Ratio (TTM) 3.63 3.3 4.1 5.27 6.83
ACOG's Total Ranking # 2962 # 3131 # # #
Accounts Receivable average collection period days 101 111 89 69 53
Seq. Receivable Change 50.55 % -15.47 % 49.2 % 52.25 % 221.12 %
Seq. Revenue Change 72.42 % 26.52 % -1.69 % 71.38 % -43.4 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 0
Healthcare Sector # 0
Overall Market # 2962

Receivable Turnover Ratio Statistics
High Average Low
4.39 3.88 3.47
(Dec 31 2025)   (Mar 31 2026)





ACOG Company Profile • Back to ACOG Efficiency Comparisons • Compare ACOG Receivables Turnover Ratio to its Competitors

Financial Statements
Alpha Cognition's Accounts Receivable $ 6 Millions Visit ACOG's Balance sheet
Alpha Cognition's Sales TTM $ 15 Millions Visit ACOG's Income Statement
Sources of ACOG's Revenues Visit ACOG's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ACOG's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ACOG's Growth Rates ACOG's Roa ACOG's Inventory Turnover Ratio ACOG's Dividend Comparisons
ACOG's Profitability Ratios ACOG's Roi ACOG's Asset Turnover Ratio ACOG's Dividend Growth
ACOG's Valuation Ratios ACOG's Roe ACOG's Financial Strength Ratios ACOG's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Seres Therapeutics Inc   7.42 $ 1.883  Millions$ 0.254  Millions
Blue Water Vaccines Inc  7.41 $ 0.646  Millions$ 0.087  Millions
Renovorx Inc   7.40 $ 1.976  Millions$ 0.267  Millions
Maravai Lifesciences Holdings Inc   7.39 $ 207.886  Millions$ 28.147  Millions
Nurix Therapeutics Inc   7.35 $ 36.766  Millions$ 5.000  Millions
Cerus Corporation  7.35 $ 221.224  Millions$ 30.111  Millions
Anteris Technologies Global Corp   7.34 $ 2.242  Millions$ 0.305  Millions
Palatin Technologies Inc   7.34 $ 13.185  Millions$ 1.797  Millions
Lucid Diagnostics Inc   7.33 $ 5.445  Millions$ 0.742  Millions
Foxo Technologies Inc   7.27 $ 24.846  Millions$ 3.420  Millions
Si bone inc   7.23 $ 214.331  Millions$ 29.648  Millions
Insmed Inc  7.18 $ 1,076.572  Millions$ 149.999  Millions
Rhythm Pharmaceuticals Inc   7.18 $ 239.918  Millions$ 33.429  Millions
Omada Health Inc   7.15 $ 308.445  Millions$ 43.147  Millions
Travere Therapeutics Inc   7.14 $ 591.330  Millions$ 82.764  Millions
Pulmonx Corporation  7.14 $ 87.393  Millions$ 12.237  Millions
Twist Bioscience Corporation  7.10 $ 431.798  Millions$ 60.812  Millions
Boston Scientific Corporation  7.10 $ 20,997.000  Millions$ 2,957.500  Millions
Angiodynamics Inc   7.08 $ 317.726  Millions$ 44.853  Millions
Quidelortho Corp  7.06 $ 2,674.200  Millions$ 378.850  Millions
Arcturus Therapeutics Holdings Inc   7.05 $ 29.368  Millions$ 4.168  Millions
Tandem Diabetes Care Inc   6.98 $ 1,037.302  Millions$ 148.542  Millions
Sutro Biopharma Inc   6.98 $ 45.702  Millions$ 6.545  Millions
Beyond Air Inc   6.98 $ 6.677  Millions$ 0.957  Millions
Myriad Genetics Inc   6.91 $ 805.900  Millions$ 116.650  Millions
Medpace Holdings Inc   6.91 $ 2,782.288  Millions$ 402.873  Millions
Ceribell Inc   6.90 $ 101.804  Millions$ 14.749  Millions
Stryker Corp  6.89 $ 25,837.000  Millions$ 3,749.000  Millions
Syndax Pharmaceuticals Inc   6.88 $ 252.004  Millions$ 36.646  Millions
Tarsus Pharmaceuticals Inc   6.85 $ 606.331  Millions$ 88.512  Millions

Date modified: 2026-10-05T11:03:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.